Study of cyclooxygenase-2 inhibitor combined with Qianliehuichun capsule on chronic pelvic pain syndrome

倪梁朝,陈伟星,李贤新,杨尚琪,刘运初,关志忱,苏泽轩
DOI: https://doi.org/10.3969/j.issn.1008-8849.2004.13.009
2004-01-01
Abstract:Objective It is to discuss the possible pathogeny and treatment choice of chronic pelvic pain syndrome (CPPS) from the direction of therapeutics.Methods 132 outpatients in which there was not statistically difference in average age, illness period and chronic prostatitis symptom index (CPSI) were divided into three groups. The group A was took celecoxib orally, the group B was took Qianliehuichun capsule orally and the group C was took celecoxib combined with Qianliehuichun capsule orally. The treatment period was 6 weeks. The changes of CPSI and ovoid body amount in prostate succus were compared before and after treatment among the three groups.Results The changes of CPSI and ovoid body amount in prostate succus after treatment had statistically differences in the three groups and in group C versus group A or B.Conclusion Inflammation reaction can induce CPPS. Both cyclooxygenase-2 inhibitor and Qianliehuichun capsule have definite therapeutic effect on chronic pelvic pain syndrome. The treatment of integrated traditional Chinese and western medicine is better than single treatment.
What problem does this paper attempt to address?